In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India

被引:10
|
作者
Singh, Satyendra Kumar [1 ]
Patwa, Dheeraj Kumar [1 ]
Tilak, Ragini [2 ]
Das, Arghya [2 ]
Singh, Tej Bali [3 ]
机构
[1] Banaras Hindu Univ, Inst Med Sci, Dept Dermatol & Venereol, Varanasi, Uttar Pradesh, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Div Biostat, Varanasi, Uttar Pradesh, India
关键词
Amphotericin-B; antifungal; dermatophytes; in vitro; resistance; voriconazole; TRICHOPHYTON-RUBRUM; RESISTANCE; ITRACONAZOLE; TERBINAFINE; AGENTS;
D O I
10.4103/ijdvl.IJDVL_319_18
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Dermatophytosis is a major public health problem in our country. Although resistance to conventional oral and topical antifungal agents is being increasingly encountered, the sensitivity pattern of dermatophytes has not been systematically analysed. Aims: We aimed to determine the sensitivity pattern of dermatophyte isolates to amphotericin B and six oral antifungal drugs. Materials and Methods: Patients with dermatophytosis attending the outpatient department of dermatology were enrolled in the study. Samples were collected for mycological examination and in vitro antifungal sensitivity testing was done by broth microdilution as per the Clinical and Laboratory Standard Institute M38-A standards. Results: A total of 804 patients were enrolled. Specimens from 185 patients (23%) were both KOH and culture positive, and 44 of these isolates (41 Trichophyton mentagrophytes and 3 Trichophyton rubrum) were subjected to sensitivity testing. Minimum inhibitory concentrations (MIC) of itraconazole, ketoconazole, voriconazole and amphotericin B were comparable. The median MIC to fluconazole was higher than the other tested drugs. Dermatophytes were most susceptible to ketoconazole and voriconazole, followed by itraconazole, amphotericin B, fluconazole and griseofulvin. A high incidence of resistance was found to terbinafine and the difference was statistically significant in comparison to fluconazole, itraconazole, voriconazole, ketoconazole (P = 0.001) and griseofulvin (P = 0.003). The strains were more sensitive to amphotericin B as compared to griseofulvin (P = 0.02) and terbinafine (P < 0.001). Limitations: This was a hospital-based study and may not reflect the true pattern in the community. Only a few of the isolates were selected for study. The clinical response of patients, whose isolates were studied for in vitro sensitivity of the antifungals, was not studied. Conclusions: The sensitivity pattern of dermatophytes to various antifungals including amphotericin B, ketoconazole, voriconazole and itraconazole were determined. The studied isolates were least susceptible to terbinafine.
引用
收藏
页码:388 / 392
页数:5
相关论文
共 50 条
  • [11] In vitro susceptibility of seven antifungal agents against dermatophytes isolated in Istanbul
    Altinbas, Rabiye
    Ozakkas, Fatma
    Baris, Ayse
    Turan, Deniz
    Sen, Sumeyye
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (03) : 615 - 619
  • [12] Comparative In Vitro Antifungal Susceptibility Activity of Amphotericin B Versus Amphotericin B Methyl Ester Against Candida albicans Ocular Isolates
    Thanathanee, Onsiri
    Miller, Darlene
    Ringel, David M.
    Schaffner, Carl P.
    Alfonso, Eduardo C.
    O'Brien, Terrence P.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 589 - 592
  • [13] In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey
    Yenisehirli, Gulgun
    Tuncoglu, Ebru
    Yenisehirli, Aydan
    Bulut, Yunus
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (12) : 1557 - 1560
  • [14] In vitro activity of six antifungal drugs against clinically important dermatophytes
    Pakshir, Keyvan
    Bahaedinie, Leila
    Rezaei, Zahra
    Sodaifi, Manuchehr
    Zomorodian, Kamiar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2009, 2 (04) : 158 - 163
  • [15] In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus
    Manavathu, EK
    Alangaden, GJ
    Chandrasekar, PH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 615 - 619
  • [16] Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
    Carrillo-Muñoz, AJ
    Quindós, G
    Tur, C
    Ruesga, M
    Alonso, R
    del Valle, O
    Rodriguez, V
    Arévalo, MP
    Salgado, J
    Martin-Mazuelos, E
    Bornay-Llinares, FJ
    del Palacio, A
    Cuétara, M
    Gasser, I
    Hernández-Molina, JM
    Pemán, J
    CHEMOTHERAPY, 2000, 46 (04) : 235 - 244
  • [17] Design of amphotericin B oral formulation for antifungal therapy
    Liu, Min
    Chen, Meiwan
    Yang, Zhiwen
    DRUG DELIVERY, 2017, 24 (01) : 1 - 9
  • [18] ORAL CANCER AWARENESS AMONG THE GENERAL PUBLIC IN ALIGARH OF UTTAR PRADESH OF INDIA
    Aggarwal, Anshul
    Asdullah, Md
    Gupta, Juhi
    Khan, Masood Hassan
    Aggarwal, Neha
    ANNALS OF DENTAL SPECIALTY, 2020, 8 (02): : 13 - 19
  • [19] Dermatophytosis in Iran: clinical, molecular characterization and in vitro antifungal susceptibility of dermatophytes isolates
    Hedayati, M. T.
    Ansari, S.
    Zomorodian, K.
    Pakshir, K.
    Badali, H.
    Rafiei, A.
    Seyedmousavi, S.
    MYCOSES, 2015, 58 : 143 - 143
  • [20] Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111
    Ghannoum, M.
    Chaturvedi, V.
    Diekema, D.
    Ostrosky-Zeichner, L.
    Rennie, R.
    Walsh, T.
    Wengenack, N.
    Fothergill, A.
    Wiederhold, N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (03) : 662 - 665